← Back to Search

Negative health-related experiences and mini-RQLQ for Patient Engagement

N/A
Waitlist Available
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age and older, living in the US, fluent written and spoken English, able to consent
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15 minutes
Awards & highlights

Study Summary

The objective of the study is to assess which health-related questionnaire is the most accurate and reliable. The hypothesis is that some health-related questionnaires are more reliable than others.

Eligible Conditions
  • Patient-Reported Outcome Measures (PROMs)
  • Patient Engagement

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
EQ-5D-5L score
PROMIS Global health v1.2 score
Rhinosinusitis Disability Index (RSDI) score
+3 more
Secondary outcome measures
Present Mood Visual Analogue Scale

Trial Design

18Treatment groups
Experimental Treatment
Active Control
Group I: Positive health-related experiences and mini-RQLQExperimental Treatment1 Intervention
Reflecting on positive health-related experiences Mini-RQLQ questionnaire
Group II: Positive health-related experiences and SNOT-22Experimental Treatment1 Intervention
Reflecting on positive health-related experiences SNOT-22 questionnaire
Group III: Positive health-related experiences and SF-36Experimental Treatment1 Intervention
Reflecting on positive health-related experiences SF-36 questionnaire
Group IV: Positive health-related experiences and RSDIExperimental Treatment1 Intervention
Reflecting on positive health-related experiences RSDI questionnaire
Group V: Positive health-related experiences and PROMISExperimental Treatment1 Intervention
Reflecting on positive health-related experiences PROMIS Global health v1.2 questionnaire
Group VI: Positive health-related experiences and EQ-5D-5LExperimental Treatment1 Intervention
Reflecting on positive health-related experiences EQ-5D-5L questionnaire
Group VII: Negative health-related experiences and mini-RQLQExperimental Treatment1 Intervention
Reflecting on negative health-related experiences Mini-RQLQ questionnaire
Group VIII: Negative health-related experiences and SNOT-22Experimental Treatment1 Intervention
Reflecting on negative health-related experiences SNOT-22 questionnaire
Group IX: Negative health-related experiences and SF-36Experimental Treatment1 Intervention
Reflecting on negative health-related experiences SF-36 questionnaire
Group X: Negative health-related experiences and RSDIExperimental Treatment1 Intervention
Reflecting on negative health-related experiences RSDI questionnaire
Group XI: Negative health-related experiences and PROMISExperimental Treatment1 Intervention
Reflecting on negative health-related experiences PROMIS Global health v1.2 questionnaire
Group XII: Negative health-related experiences and EQ-5D-5LExperimental Treatment1 Intervention
Reflecting on negative health-related experiences EQ-5D-5L questionnaire
Group XIII: Control and mini-RQLQActive Control1 Intervention
No intervention/ control group Mini-RQLQ questionnaire
Group XIV: Control and EQ-5D-5LActive Control1 Intervention
No intervention/ control group EQ-5D-5L questionnaire
Group XV: Control and PROMISActive Control1 Intervention
No intervention/ control group PROMIS Global health v1.2 questionnaire
Group XVI: Control and SF-36Active Control1 Intervention
No intervention/ control group SF-36 questionnaire
Group XVII: Control and SNOT-22Active Control1 Intervention
No intervention/ control group SNOT-22 questionnaire
Group XVIII: Control and RSDIActive Control1 Intervention
No intervention/ control group RSDI questionnaire
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Reflection on health-related experiences
2021
N/A
~900

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,428 Previous Clinical Trials
2,459,220 Total Patients Enrolled
2 Trials studying Patient Engagement
263 Patients Enrolled for Patient Engagement
Northwestern UniversityOTHER
1,584 Previous Clinical Trials
916,865 Total Patients Enrolled
1 Trials studying Patient Engagement
314 Patients Enrolled for Patient Engagement
Medical University of South CarolinaOTHER
931 Previous Clinical Trials
7,393,136 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Priming and Patient Reported Outcome Measures
Nathan Yang 2021. "Priming and Patient Reported Outcome Measures". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05229016.
~263 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top